Chesney C M, Crofton J T, Pifer D D, Brooks D P, Huch K M, Share L
J Lab Clin Med. 1985 Sep;106(3):314-8.
It has recently been reported that 90% of circulating vasopressin in humans appears to be in platelets. We have confirmed these results and studied the subcellular localization and secretion of vasopressin from human platelets. Sucrose density gradient analysis showed highest relative specific activity for vasopressin in the membrane fractions. Stirring of platelet-rich plasma with a number of different platelet-aggregating agents including epinephrine, norepinephrine, arachidonic acid, collagen, adenosine diphosphate, A23187, and platelet-activating factor failed to release significant amounts of immunoreactive vasopressin, despite the expected aggregation and secretion of platelet factor 4 by these agents. Thus vasopressin appears to be primarily a platelet membrane component and is not secreted in the usual way by agents modulating platelet function.
最近有报道称,人类循环中的血管加压素90%似乎存在于血小板中。我们已证实这些结果,并研究了血管加压素在人血小板中的亚细胞定位及分泌情况。蔗糖密度梯度分析显示,膜组分中血管加压素的相对比活性最高。用多种不同的血小板聚集剂(包括肾上腺素、去甲肾上腺素、花生四烯酸、胶原蛋白、二磷酸腺苷、A23187和血小板激活因子)搅拌富血小板血浆,尽管这些试剂预期会使血小板因子4聚集和分泌,但未能释放出大量的免疫反应性血管加压素。因此,血管加压素似乎主要是血小板膜的一种成分,并且不会被调节血小板功能的试剂以通常的方式分泌。